Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKG1 | Q13976 | 5/20 | 0.79 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.79 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.79 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.79 |
| ▸ | PRKCG | P05129 | 2/20 | 0.79 |
| ▸ | CDK1 | P06493 | 2/20 | 0.79 |
| ▸ | PIM1 | P11309 | 2/20 | 0.79 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.79 |
| ▸ | PRKACA | P17612 | 2/20 | 0.79 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.79 |
| ▸ | CDK2 | P24941 | 2/20 | 0.79 |
| ▸ | MARK3 | P27448 | 2/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.79 |
| ▸ | FLT4 | P35916 | 2/20 | 0.79 |
| ▸ | FLT3 | P36888 | 2/20 | 0.79 |
| ▸ | CLK2 | P49760 | 2/20 | 0.79 |
| ▸ | GSK3A | P49840 | 2/20 | 0.79 |
| ▸ | GSK3B | P49841 | 2/20 | 0.79 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.79 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3614343 | 0.89 | PRKG1 (1.00) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL27838920 | 0.86 | ROCK1 (0.60) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL3602313 | 0.83 | PRKG1 (0.64) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL3606604 | 0.76 | CDK2 (0.78) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL3603600 | 0.76 | CDK2 (0.78) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL27819450 | 0.75 | ROCK1 (0.76) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL14493878 | 0.75 | CCNT1 (0.50) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL3604802 | 0.74 | ROCK1 (0.48) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL3602220 | 0.74 | AKT3 (0.61) | PRKG1CHEK1MAP4K4CHEK2PRKCG | |
| SCHEMBL18129636 | 0.74 | CHEK1 (0.67) | PRKG1CHEK1MAP4K4CHEK2PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100035919-A1 | COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES | ABBOTT LABORATORIES (US) | 2010-02-11 | — | — | US | claimed |
| US-20100035919-A1 | COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES | ABBOTT LABORATORIES (US) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035919-A1 | COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES | ROCK1, ROCK2, RHOA | PRKG1 40/4885CHEK1 434/4885MAP4K4 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.